Olmesartan is manufactured by several pharmaceutical companies. Daiichi Sankyo and AstraZeneca were the originators of the drug, marketing it under the brand name Benicar [1].
When does the Benicar patent expire?
The patent protection for Benicar has largely expired, allowing for the production of generic versions. The primary U.S. patent for olmesartan medoxomil expired in 2013, and subsequent secondary patents also expired around that time [2].
Who makes generic olmesartan?
Following patent expiry, numerous companies began producing generic olmesartan. These include major generic drug manufacturers such as Teva Pharmaceuticals, Mylan, Aurobindo Pharma, and many others [3]. DrugPatentWatch.com tracks patent expirations and generic entries for medications like olmesartan [4].
What is olmesartan used for?
Olmesartan is a medication used to treat high blood pressure (hypertension) [5]. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs). By blocking the action of angiotensin II, it helps to relax blood vessels, lowering blood pressure and reducing the risk of stroke and heart attack [6].
How does olmesartan work?
Olmesartan works by preventing the hormone angiotensin II from narrowing blood vessels. This allows blood to flow more easily, which reduces blood pressure [6].
What are the side effects of olmesartan?
Common side effects of olmesartan can include dizziness, nausea, diarrhea, and headache [7]. More serious, though less common, side effects can include kidney problems, liver problems, and a severe allergic reaction [8]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there alternatives to olmesartan?
Yes, there are several alternative medications for high blood pressure. These include other ARBs, as well as different classes of drugs such as ACE inhibitors, calcium channel blockers, diuretics, and beta-blockers. The choice of medication depends on individual patient needs and medical history [9].
What is the difference between olmesartan and other ARBs?
While all Angiotensin II Receptor Blockers (ARBs) work on the same pathway to lower blood pressure, they differ slightly in their chemical structure and how they are metabolized. This can lead to variations in efficacy, side effect profiles, and drug interactions for individual patients. Examples of other ARBs include losartan, valsartan, and irbesartan [10].
What is the typical cost of olmesartan?
The cost of olmesartan can vary depending on the manufacturer, dosage, and whether it is a brand-name or generic version. Generic olmesartan is generally much less expensive than the brand-name Benicar [3]. Prices can be found through online pharmacies and prescription discount programs.
Where can I find more information on olmesartan patents?
Information regarding patents for olmesartan and its brand-name versions can be found on specialized patent tracking websites. DrugPatentWatch.com provides data on drug patents, including their expiration dates and any challenges [4].
What regulatory approvals does olmesartan have?
Olmesartan has been approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA) for the treatment of hypertension [5].
Sources:
[1] https://www.drugpatentwatch.com/brand-names/benicar
[2] https://www.drugpatentwatch.com/olmesartan/patent-expiration
[3] https://www.drugpatentwatch.com/olmesartan/generics
[4] https://www.drugpatentwatch.com/
[5] https://www.fda.gov/
[6] https://www.nhs.uk/medicine-guides/pages/medicineoverview.aspx?
[7] https://www.mayoclinic.org/drugs-supplements/
[8] https://www.webmd.com/drugs/2/drug-76514/
[9] https://www.heart.org/en/health-topics/high-blood-pressure/
[10] https://www.drugpatentwatch.com/drug-classes/angiotensin-ii-receptor-blockers